Market Trends Influencing Strategic Decisions in the Acute Kidney Injury Industry: FDA Approval Granted For Phase II Clinical Trial Of Novel Acute Kidney Injury Treatment

Global Acute Kidney Injury Market

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Fast Is The Acute Kidney Injury Market Expected to Grow Between 2025 And 2029?

The market size for acute kidney injury has seen substantial growth in recent few years. The market is projected to rise from $5.37 billion in 2024 to $5.72 billion in 2025, with a compound annual growth rate (CAGR) of 6.6%. The historical growth trend is due to factors such as the growing numbers of chronic diseases, an uptick in aging population, a rise in hospital-acquired infections, heightened awareness around kidney health, and progress in critical care medicine.

Anticipations suggest that the acute kidney injury market size will undergo substantial growth in the coming years. It is projected to escalate to$7.33 billion by 2029 with a compound annual growth rate (CAGR) of 6.4%. The expansion expected in the forecast period is credited to the rising incidence of sepsis, growing inclination toward personalized treatment, amplified governmental health initiatives, increased health spending in burgeoning markets, and an elevated emphasis on personalized medicine and regenerative therapies. Key trends occurring during the forecast period include advancements in wearable dialysis gadgets, AI incorporation in treatment optimization, compact renal replacement therapy systems, developments in continuous renal replacement therapy (CRRT), the advent of remote monitoring and the inclusion of telemedicine.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21079&type=smp

What Are the Major Market Drivers Behind the Rising Adoption of Acute Kidney Injury Market?

The surge in diabetes occurrences is anticipated to boost the acute kidney injury market’s expansion. Diabetes is a collection of metabolic disorders characterized by elevated blood glucose levels, either because the body does not produce sufficient insulin or because cells do not react appropriately to insulin. Growing obesity rates, unhealthy diets, inactive lifestyles, aging populations, and improved awareness and diagnosis are some of the factors contributing to the rising incidence of diabetes. Acute kidney injury induces metabolic and inflammatory alterations that can impact insulin resistance and glucose balance, indicating a complex interaction that could affect diabetes development and management. For example, in March 2024, the UK government’s Office for Health Improvement & Disparities reported that between March 2022 and March 2023, the percentage of individuals with type 1 diabetes undergoing all eight recommended care processes experienced a 22% increase, and for type 2 diabetes, it rose by 21%. Moreover, the percentage of individuals meeting the target HbA1c levels increased to 37.9%, a record high as per the National Diabetes Audit (NDA). Consequently, the rising prevalence of diabetes is boosting the acute kidney injury market’s growth.

Which Key Market Segments Comprise the Acute Kidney Injury Market and Drive Its Revenue Growth?

The acute kidney injurymarket covered in this report is segmented –

1) By Injury: Pre-Renal Kidney Injury; Post-Renal Kidney Injury; Intrinsic Kidney Injury

2) By Treatment Type: Dialysis; Drug Therapy; Urinary Implants

3) By End User: Hospitals; Ambulatory Surgical Centers; Other End Users

Subsegments:

1) By Pre-Renal Kidney Injury: Hypovolemia; Heart Failure-Related Injury; Sepsis-Induced Injury; Renal Artery Stenosis; Hepatorenal Syndrome

2) By Post-Renal Kidney Injury: Ureteral Obstruction; Bladder Outlet Obstruction; Prostate Enlargement (Benign Prostatic Hyperplasia); Kidney Stones; Tumors Affecting Urinary Tract

3) By Intrinsic Kidney Injury: Acute Tubular Necrosis (ATN); Acute Interstitial Nephritis (AIN); Glomerulonephritis; Vasculitis; Rhabdomyolysis-Induced Injury

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=21079&type=smp

Which Areas Are Leading Regions in the Acute Kidney Injury Market Expansion Across the Globe?

North America was the largest region in the acute kidney injury market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the acute kidney injury market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Strategic Trends Steering theAcute Kidney Injury Market Direction?

Prominent businesses in the acute kidney injury (AKI) marketplace are working towards gaining regulatory confirmations to amplify their product ranges and propose innovative treatments. These regulatory confirmations involve formal authorizations issued by official bodies such as the FDA or EMA, permitting a product to be sold and marketed provided it meets certain standards concerning safety, efficacy, and quality. For instance, Mission Therapeutics Ltd., a biotechnology firm based in the UK, was granted permission by the FDA in December 2023 to begin a Phase II clinical trial for its primary asset, MTX652, aimed at addressing acute kidney injury (AKI) in patients at elevated risk post-cardiac surgery. This trial is orchestrated to target important pathways associated with kidney injury and repair with the intention to mitigate inflammation, avert additional kidney damage, and enable recovery. The hallmark feature of this trial is its emphasis on exploiting innovative therapeutic mechanisms to tackle the root molecular causes of AKI, potentially revealing more efficient treatment alternatives than the ones currently available. The Phase II trial is set to assess the safety, efficacy, and pharmacokinetics of MTX652, producing vital data that could further clinical utilization and possible approval.

View the full report here:

https://www.thebusinessresearchcompany.com/report/acute-kidney-injury-global-market-report

How Is the Acute Kidney Injury Market Conceptually Defined?

Acute kidney injury (AKI) refers to a sudden decline in kidney function, leading to an accumulation of waste products, electrolytes, and fluids in the body. It can develop rapidly over hours or days and is often caused by conditions like reduced blood flow, direct kidney damage, or obstruction of the urinary tract.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21079

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model